Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration

American Journal of Health-System Pharmacy

Volumn 61, Issue 21, 2004, Pages 2289-2293

  Trissel, Lawrence A ^a   Saenz, Christopher A ^a   Ogundele, Abayomi B ^b   Ingram, Delshalonda S ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TEXAS SOUTHERN UNIVERSITY   (United States)

Author keywords

Antiinfective agents; Antineoplastic agents; Caloric agents; Color; Dextrose; Diluents; Incompatibilities; Injections; Pemetrexed disodium; Precipitation; Sodium chloride; Stability; Storage; Turbidity

Indexed keywords

AMIFOSTINE; AMINOPHYLLINE; BUMETANIDE; BUPRENORPHINE; BUTORPHANOL TARTRATE; CARBOPLATIN; CIMETIDINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE SODIUM PHOSPHATE; DIPHENHYDRAMINE; DOBUTAMINE; DOCETAXEL; DOPAMINE; DOXORUBICIN; DROPERIDOL; FLUOROURACIL; GEMCITABINE; GLUCONATE CALCIUM; IFOSFAMIDE; IRINOTECAN; MITOXANTRONE; PACLITAXEL; PEMETREXED; RAZOXANE; TOPOTECAN; UNINDEXED DRUG; VINBLASTINE SULFATE; VINCRISTINE SULFATE;

ARTICLE; CHEMICAL REACTION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ANALYSIS; DRUG INFUSION; DRUG MIXTURE; FLUORESCENT LIGHTING; HUMAN; INJECTION SITE; PHOTOMETRY; PRECIPITATION; PRIORITY JOURNAL; SIMULATION; TURBIDIMETRY; TURBIDITY; VISUAL DISCRIMINATION;

EID: 12544251395     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.21.2289     Document Type: Article

References (5)

1. Bertino J, Allegra C, Calvert H. MTA, a multitargeted antifolate from preclinical to Phase I and beyond. Semin Oncol. 1999; 26(suppl 6):1-111.
2. Allen LV Jr, Levinson RS, Phisutsinthop D. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Am J Hosp Pharm. 1977; 34:939-43.
3. Trissel LA, Martinez JF. Physical compatibility of melphalan with selected drugs during simulated Y-site administration. Am J Hosp Pharm. 1993; 50:2359-63.
4. Trissel LA, Bready BB. Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection. Am J Hosp Pharm. 1992; 49:1716-9.
5. Trissel LA, Martinez JF. Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection, part 2. Am J Hosp Pharm. 1993; 50:300-4.